Candidate Nomination
In this phase we characterize the most promising leads from the lead optimization phase with the aim of producing a data package ready to submit for investigational new drug (ind). Approaches we use include:
- Full characterization of compounds for promotionto development
- Focused ADME around a specific dosage form
- Early toxicity studies including genotoxicity and carcinogenicity